Christina Møller Andreasen

Christina Møller Andreasen

Auto-generated profile, based on publicly available information

Christina Møller Andreasen

Research Unit of Pathology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Bone
Verified
Journal Article
Open access
Jean-Marie DelaisseJean-Marie Delaisse
Jean-Marie Delaisse
TAThomas Levin Andersen
Thomas Levin Andersen
HKHelene Bjoerg Kristensen
Helene Bjoerg Kristensen
PJPia Rosgaard Jensen
Pia Rosgaard Jensen
CAChristina Møller Andreasen
Christina Møller Andreasen
Kent SøeKent Søe
Kent Søe
Proper bone remodeling necessarily requires that osteoblasts reconstruct the bone that osteoclasts have resorbed. However, the cellular events connecting resorption to reconstruction have remained poorly known. The consequence is a fragmentary understanding of the remodeling cycle where only the resorption and formation steps are taken into account. New tools have recently made possible to elucidate how resorption shifts to formation, thereby allowing to comprehend the remodeling cycle as a whole. This new knowledge is reviewed herein. It shows how teams of osteoclasts and osteoblast lineage cells are progressively established and how they are subjected therein to reciprocal interactions. Contrary to the common view, osteoclasts and osteoprogenitors are intermingled on the eroded surfaces. The analysis of the resorption and cell population dynamics shows that osteoprogenitor cell expansion and resorption proceed as an integrated mechanism; that a threshold cell density of osteoprogenitors on the eroded surface is mandatory for onset of bone formation; that the cell initiating osteoprogenitor cell expansion is the osteoclast; and that the osteoclast therefore triggers putative osteoprogenitor reservoirs positioned at proximity of the eroded bone surface (bone lining cells, canopy cells, pericytes). The interplay between magnitude of resorption and rate of cell expansion governs how soon bone reconstruction is initiated and may determine uncoupling and permanent bone loss if a threshold cell density is not reached. The clinical perspectives opened by these findings are discussed.

1 December 2015 in Bone Research
Verified
Journal Article
Open access
DMDitte Mh Merrild
Ditte Mh Merrild
DPDinisha C Pirapaharan
Dinisha C Pirapaharan
CAChristina M Andreasen
Christina M Andreasen
PKPer Kjærsgaard-Andersen
Per Kjærsgaard-Andersen
AMAnaïs M. J. Møller
Anaïs M. J. Møller
Kent SøeKent Søe
Kent Søe
Osteoclasts (OCs) seeded on bone slices either drill round pits or dig long trenches. Whereas pits correspond to intermittent resorption, trenches correspond to continuous and faster resorption and require a distinct assembly of the resorption apparatus. It is unknown whether the distinction between pits and trenches has any biological relevance. Using OCs prepared from different blood donors, we found that female OCs achieved increased resorption mainly through pit formation, whereas male OCs did so through trench formation. Trench formation went along with high collagenolytic activity and high cathepsin K (CatK) expression, thereby allowing deeper demineralization. A specific CatK inhibitor abrogated the generation of trenches, while still allowing the generation of pits. OCs obtained from bone marrow were more prone to generate trenches than those obtained from blood. Scanning electron microscopy of bone surfaces eroded in vivo showed trenches and pits of similar size as those made by OCs in culture. We conclude that the distinction between trench- and pit-forming OCs is relevant to the differences among OCs from different skeletal sites, different individuals, including gender, and results from differences in collagenolytic power. This indicates a biological relevance and highlights the importance of discriminating between pits and trenches when assessing resorption.

18 October 2024 in Bone Research
Verified
Journal Article
Open access
PDF file
BEBilal M. El-Masri
Bilal M. El-Masri
CAChristina M. Andreasen
Christina M. Andreasen
KLKaja S. Laursen
Kaja S. Laursen
VKViktoria B. Kofod
Viktoria B. Kofod
XBXenia Goldberg Borggaard
Xenia Goldberg Borggaard
TAThomas L. Andersen
Thomas L. Andersen
Denosumab is a monoclonal anti-RANKL antibody that inhibits bone resorption, increases bone mass, and reduces fracture risk. Denosumab discontinuation causes an extensive wave of rebound resorption, but the cellular mechanisms remain poorly characterized. We utilized in situ hybridization (ISH) as a direct approach to identify the cells that activate osteoclastogenesis through the RANKL/OPG pathway. ISH was performed across species, skeletal sites, and following recombinant OPG (OPG:Fc) and parathyroid hormone 1–34 (PTH) treatment of mice. OPG:Fc treatment in mice induced an increased expression of RANKL mRNA mainly in trabecular, but not endocortical bone surface cells. Additionally, a decreased expression of OPG mRNA was detected in bone surface cells and osteocytes of both compartments. A similar but more pronounced effect on RANKL and OPG expression was seen one hour after PTH treatment. These findings suggest that bone surface cells and osteocytes conjointly regulate the activation of osteoclastogenesis, and that OPG:Fc treatment induces a local accumulation of osteoclastogenic activation sites, ready to recruit and activate osteoclasts upon treatment discontinuation. Analysis of publicly available single-cell RNA sequencing (scRNAseq) data from murine bone marrow stromal cells revealed that Tnfsf11+ cells expressed high levels of Mmp13, Limch1, and Wif1, confirming their osteoprogenitor status. ISH confirmed co-expression of Mmp13 and Tnfsf11 in bone surface cells of both vehicle- and OPG:Fc-treated mice. Under physiological conditions of human/mouse bone, RANKL is expressed mainly by osteoprogenitors proximate to the osteoclasts, while OPG is expressed mainly by osteocytes and bone-forming osteoblasts.

29 November 2017 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
CAChristina Møller Andreasen
Christina Møller Andreasen
Jean-Marie DelaisseJean-Marie Delaisse
Jean-Marie Delaisse
BEBram Cj van der Eerden
Bram Cj van der Eerden
JLJohannes P.T.M. Van Leeuwen
Johannes P.T.M. Van Leeuwen
MDMing Ding
Ming Ding
TAThomas Levin Andersen
Thomas Levin Andersen
: Intracortical bone remodeling normally ensures maintenance of the cortical bone matrix and strength, but during aging, this remodeling generates excessive porosity. The mechanism behind the age-induced cortical porosity is poorly understood and addressed in the present study. This study consists of a histomorphometric analysis of sections of iliac bone specimens from 35 women (age 16–78 years). First, the study shows that the age-induced cortical porosity reflects an increased pore size rather than an increased pore density. Second, it establishes a novel histomorphometric classification of the pores, which is based on the characteristics of the remodeling sites to which each pore is associated. It takes into consideration (i) the stage of the remodeling event at the level where the pore is sectioned, (ii) whether the event corresponds with the generation of a new pore through penetrative tunneling (type 1 pores) or with remodeling of an existing pore (type 2 pores), and (iii) in the latter case, whether or not the new remodeling event leads to the coalescence of pores. Of note, the advantage of this classification is to relate porosity with its generation mechanism. Third, it demonstrates that aging and porosity are correlated with: a shift from type 1 to type 2 pores, reflecting that the remodeling of existing pores is higher; an accumulation of eroded type 2 pores, reflecting an extended resorption-reversal phase; and a coalescence of these eroded type 2 pores into enlarged coalescing type 2 cavities. Collectively, this study supports the notion, that age-related increase in cortical porosity is the result of intracortical remodeling sites upon existing pores, with an extended reversal-resorption phase (eroded type 2 pores) that may likely result in a delayed or absent initiation of the subsequent bone formation. © 2017 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals Inc.


10 August 2020 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
JBJulia Brun
Julia Brun
CAChristina Møller Andreasen
Christina Møller Andreasen
CECharlotte Ejersted
Charlotte Ejersted
TAThomas Levin Andersen
Thomas Levin Andersen
JCJoseph Caverzasio
Joseph Caverzasio
CTCyril Thouverey
Cyril Thouverey
The physiological functions of platelet‐derived growth factor receptors (PDGFRs) α and β in osteoblast biology and bone metabolism remain to be established. Here, we show that PDGFRA and PDGFRB genes are expressed by osteoblast‐lineage canopy and reversal cells in close proximity to PDGFB ‐expressing osteoclasts within human trabecular bone remodeling units. We also report that, while removal of only one of the two PDGFRs in Osterix ‐positive cells does not affect bone phenotype, suppression of both PDGFRs in those osteoblast lineage cells increases trabecular bone volume in male mice as well as in female gonad‐intact and ovariectomized mice. Furthermore, osteoblast lineage‐specific suppression of PDGFRs reduces Csf1 expression, bone marrow level of M‐CSF, number of osteoclasts and therefore, bone resorption, but does not change bone formation. Finally, abrogation of PDGFR signaling in osteoblasts blocks PDGF‐induced ERK1/2‐mediated Csf1 expression and M‐CSF secretion in osteoblast cultures, and calcitriol‐mediated osteoclastogenesis in co‐cultures. In conclusion, our results indicate that PDGFR signaling in osteoblast lineage cells controls bone resorption through ERK1/2‐mediated Csf1 expression.